Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |
mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |